Market Eyes LiveHenry Schein Inc (HSIC) Stock Rating & Analysis
MELANY's data-driven read on Henry Schein Inc · Wholesale-Medical, Dental & Hospital Equipment & Supplies.
Henry Schein Inc is a solutions company for healthcare professionals, providing healthcare equipment, products, and services to office-based dental and medical practitioners as well as alternative sites of care. Its reportable segments are Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology.
Why HSIC scores 59/100
MELANY scores Henry Schein Inc 59/100 by weighing eight factors. Here is how HSIC breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 14.9x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for HSIC
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Henry Schein Inc sits in the Healthcare sector theme, which MELANY currently rates 56/100 for strength. Theme strength feeds HSIC's momentum and catalyst factors above.
Tracking HSIC
Henry Schein Inc rates Hold right now, so MELANY is not flagging a fresh entry. Create a free account to add HSIC to your watchlist and get alerted the moment the rating changes.
How MELANY rates HSIC
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Henry Schein Inc's 59/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about HSIC
Is Henry Schein Inc (HSIC) a buy?
As of 2026-08-25, MELANY rated Henry Schein Inc Hold with a composite score of 59/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Henry Schein Inc's MELANY score?
Henry Schein Inc (HSIC) has a MELANY composite score of 59/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the HSIC stock rating calculated?
MELANY scores HSIC from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Henry Schein Inc stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Henry Schein Inc (HSIC) Hold with a composite of 59/100 as of 2026-08-25. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the HSIC stock price forecast?
MELANY does not publish price targets or forecasts for HSIC. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 59/100 across eight factors for Henry Schein Inc, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is HSIC stock overvalued or undervalued?
MELANY's valuation factor currently reads 60/100 for Henry Schein Inc, where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives HSIC's read.
What price should I buy HSIC at?
MELANY is not flagging a fresh entry for HSIC at its current Hold rating, so there is no entry zone to publish right now. Watchlisting HSIC in the free app gets you alerted the moment that changes.
What are the risks of buying HSIC stock?
The top risks MELANY currently flags for Henry Schein Inc: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Henry Schein Inc a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 40/100 for Henry Schein Inc, and earnings track record, at 77/100. The 59/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will HSIC stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 71/100 for HSIC right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this HSIC rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-25. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores HSIC continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
HSIC's live rating and alerts are free either way. The app is our flagship.